Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy. The study involved 52 patients with high-grade STS, with a median ...
Triple-negative breast cancer is an aggressive breast cancer subtype, and there remains an unmet need to improve outcomes in patients with previously untreated, programmed death ligand 1 ...
My second grader’s public school is full of warm, caring educators and decent support for students working below grade level. His class is big and rowdy, with a single teacher and a majority of kids ...
It’s good to see that high-end audio manufacturing is still thriving in Europe with brands like Linn, Naim, Quad, Focal and Volumio producing some truly innovative products. Volumio is an Italian ...
TL;DR: Samsung's HDR10+ Advanced enhances HDR technology with features like HDR10+ Bright for brighter images, HDR10+ Genre for content-specific tone mapping, Intelligent FRC for improved motion ...
Our 2-year-old daughter, “Daisy,” started a new daycare program over the summer. Her lead teacher ran an in-home daycare for 20 years before moving to this center, and she has what we consider to be ...
The technology is still in development, but is expected to be at CES 2026. The technology is still in development, but is expected to be at CES 2026. is a senior reviewer covering TVs and audio. He ...
A new research paper from Google DeepMind proposes a new AI search ranking algorithm called BlockRank that works so well it puts advanced semantic search ranking within reach of individuals and ...
IO102-IO103 plus Keytruda improved median PFS by 8.4 months over Keytruda alone in advanced melanoma patients. The combination therapy showed a significant PFS benefit in PD-L1–negative patients, with ...
Human epidermal growth factor receptor 2 (HER2)–directed antibody–drug conjugate monotherapy has shown preliminary clinical efficacy in patients with chemotherapy-refractory HER2-positive locally ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...